|
TRIM13 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.018600E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.030000E-01 |
| Normal-vs-Stage2 |
6.222600E-01 |
| Normal-vs-Stage3 |
5.205800E-01 |
| Normal-vs-Stage4 |
3.290600E-01 |
| Stage1-vs-Stage2 |
9.464400E-01 |
| Stage1-vs-Stage3 |
3.222400E-01 |
| Stage1-vs-Stage4 |
2.047400E-01 |
| Stage2-vs-Stage3 |
4.186200E-01 |
| Stage2-vs-Stage4 |
2.702600E-01 |
| Stage3-vs-Stage4 |
8.476200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.613600E-01 |
| Normal-vs-AfricanAmerican |
8.149000E-01 |
| Normal-vs-Asian |
1.567500E-02 |
| Caucasian-vs-AfricanAmerican |
6.345600E-01 |
| Caucasian-vs-Asian |
1.091980E-01 |
| AfricanAmerican-vs-Asian |
9.614500E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.853000E-01 |
| Normal-vs-Female |
6.558800E-01 |
| Male-vs-Female |
8.359800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
9.163200E-01 |
| Normal-vs-Extreme_Weight |
7.471200E-01 |
| Normal-vs-Obese |
2.616600E-01 |
| Normal-vs-Extreme_Obese |
6.100800E-01 |
| Normal_Weight-vs-Extreme_Weight |
7.284000E-01 |
| Normal_Weight-vs-Obese |
4.068200E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.986000E-01 |
| Extreme_Weight-vs-Obese |
1.859830E-01 |
| Extreme_Weight-vs-Extreme_Obese |
6.566000E-01 |
| Obese-vs-Extreme_Obese |
6.912200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.170000E-02 |
| Normal-vs-Age(41-60Yrs) |
1.763500E-02 |
| Normal-vs-Age(61-80Yrs) |
7.976800E-01 |
| Normal-vs-Age(81-100Yrs) |
3.000400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.815400E-03 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.459580E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.011800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.824500E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.981700E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.255000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.636380E-02 |
| Normal-VS-Type2 PRCC |
4.851600E-02 |
| Normal-VS-KIRP CIMP |
1.9327000000402E-08 |
| Normal-VS-Unclassified PRCC |
1.205830E-01 |
| Type1 PRCC-VS-Type2 PRCC |
4.30970000000475E-05 |
| Type1 PRCC-VS-KIRP CIMP |
2.30404584300459E-12 |
| Type1 PRCC-VS-Unclassified PRCC |
7.184800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
5.41090000027999E-07 |
| Type2 PRCC-VS-Unclassified PRCC |
4.064200E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
7.00619999793872E-08 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.942000E-01 |
| Normal-vs-N1 |
6.880800E-01 |
| Normal-vs-N2 |
2.849500E-02 |
| N0-vs-N1 |
9.978200E-01 |
| N0-vs-N2 |
2.601400E-01 |
| N1-vs-N2 |
5.182000E-01 |
|
|
